Enhanced Immunoreceptor Tyrosine-based Activation Motif Signaling is Related to Pathological Bone Resorption During Critical Illness
暂无分享,去创建一个
G. Van den Berghe | T. Janssens | J. Gunst | E. van Herck | A. Wauters | S. V. Van Cromphaut | I. Vanhees | H. Owen
[1] A. Zannettino,et al. The immunoreceptor tyrosine-based activation motif (ITAM) -related factors are increased in synovial tissue and vasculature of rheumatoid arthritic joints , 2012, Arthritis Research & Therapy.
[2] R. Zhao. Immune Regulation of Osteoclast Function in Postmenopausal Osteoporosis: A Critical Interdisciplinary Perspective , 2012, International journal of medical sciences.
[3] G. Van den Berghe,et al. Critical illness‐related bone loss is associated with osteoclastic and angiogenic abnormalities , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] K. Sanjai,et al. Evaluation and comparison of decalcification agents on the human teeth , 2012, Journal of oral and maxillofacial pathology : JOMFP.
[5] E. Schwarz,et al. Regulation of human osteoclast development by dendritic cell‐specific transmembrane protein (DC‐STAMP) , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] Liesbet Geris,et al. The combined bone forming capacity of human periosteal derived cells and calcium phosphates. , 2011, Biomaterials.
[7] P. Stow,et al. Skeletal morbidity among survivors of critical illness* , 2011, Critical care medicine.
[8] R. Bellomo,et al. Ionized calcium concentration and outcome in critical illness* , 2011, Critical care medicine.
[9] Chen Bei,et al. Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid , 2010, Acta orthopaedica.
[10] Gerhard Hawa,et al. Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. , 2010, The Journal of clinical endocrinology and metabolism.
[11] E. Schwarz,et al. CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritis , 2010, Arthritis research & therapy.
[12] Shannon S Carson,et al. Chronic critical illness. , 2010, American journal of respiratory and critical care medicine.
[13] G. Van den Berghe,et al. Metabolic aspects of critical illness polyneuromyopathy , 2009, Critical care medicine.
[14] H. Hagino,et al. Comparison of osteoclast precursors in peripheral blood mononuclear cells from rheumatoid arthritis and osteoporosis patients , 2008, Journal of Bone and Mineral Metabolism.
[15] I. Martin,et al. In Vitro Osteogenic Differentiation and In Vivo Bone-Forming Capacity of Human Isogenic Jaw Periosteal Cells and Bone Marrow Stromal Cells , 2005, Annals of surgery.
[16] A. Mócsai,et al. The immunomodulatory adapter proteins DAP12 and Fc receptor γ-chain (FcRγ) regulate development of functional osteoclasts through the Syk tyrosine kinase , 2004 .
[17] P. Rüegsegger,et al. Corticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomography , 2004, European Journal of Clinical Pharmacology.
[18] G. Van den Berghe,et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.
[19] P. Marie,et al. S12911-2 reduces bone loss induced by short-term immobilization in rats. , 2003, Bone.
[20] G. Berghe. Endocrine evaluation of patients with critical illness. , 2003 .
[21] G. Van den Berghe,et al. Bone turnover in prolonged critical illness: effect of vitamin D , 2003, The Journal of clinical endocrinology and metabolism.
[22] S. Miller,et al. Effects of Thermal Injury on Skeletal Metabolism in Two Strains of Mice , 2002, Calcified Tissue International.
[23] S. Ralston,et al. Increased bone resorption in the critically ill: Association with sepsis and increased nitric oxide production , 2002, Critical care medicine.
[24] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[25] A. Parfitt. The Bone Remodeling Compartment: A Circulatory Function for Bone Lining Cells , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[26] J. Mechanick,et al. Biochemical response to treatment of bone hyperresorption in chronically critically ill patients. , 2000, Chest.
[27] J. Souberbielle,et al. Differences in the Capacity of Several Biochemical Bone Markers to Assess High Bone Turnover in Early Menopause and Response to Alendronate Therapy , 2000, Osteoporosis International.
[28] G. Van den Berghe,et al. Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. , 1998, The Journal of clinical endocrinology and metabolism.
[29] R. Eastell,et al. Histomorphometric and biochemical characterization of bone following acute severe burns in children. , 1995, Bone.
[30] L. Broemeling,et al. Long-term reduction in bone mass after severe burn injury in children. , 1995, The Journal of pediatrics.
[31] D. Vanderschueren,et al. Homologous radioimmunoassay of human osteocalcin. , 1992, Clinical chemistry.
[32] J. Alexander,et al. Enteral feeding in burn hypermetabolism: nutritional and metabolic effects of different levels of calorie and protein intake. , 1985, JPEN. Journal of parenteral and enteral nutrition.